new treatments (see sidebar on Building Blocks to Further
Robust, Sustained, and
Predictable Funding Increases for
Federal grants from the NIH and NCI represent the
lifeblood of biomedical research and form the foundation
upon which the majority of scientific and medical
discoveries are made. Bipartisan support for the NIH and
NCI since President Nixon signed the National Cancer Act
into law 44 years ago has resulted in extraordinary progress
against cancer, as detailed in this report. In addition to
saving lives, the federal investments in cancer research have
also spurred our economy by creating jobs and establishing
entirely new industries, such as the biotechnology industry.
Although prior federal investments in the NIH and NCI
have led to significant progress, the purchasing power of
the NIH has decreased by 25 percent since 2004 (see Figure
18, p. 106). To regain momentum and accelerate the pace
of progress, we must provide the NIH and NCI with the
resources it needs to continue to fund lifesaving research.
Enhancing Support for
Regulatory Science and
Policy Activities at the FDA
The FDA represents an integral part of the biomedical
research community (see sidebar on The Biomedical
Research Community, p. 9), and the support of this
critical agency through government funding is crucial in
continuing our progress against cancer and the delivery of
safe, effective, and precise medicines to patients residing in
the United States.
To keep pace with the rapid progress we are seeing in
biomedical research, particularly in the area of precision
medicine, the FDA is increasingly focused on advancing
regulatory science, which is the study of developing new
tools, standards, and approaches to assess the safety, efficacy,
quality, validity, and performance of medical products.
The regulatory science initiatives of the FDA are aimed
at promoting and developing evidence-based regulatory
policies that balance innovation and the expedited approval
of medical products with patient safety (166).
It is imperative that the FDA is supported in its efforts
to keep abreast of the latest scientific and technological
69% of voters
say increasing federal funding for
medical research should be a
top priority for congress.
Source: A 2015 national survey conducted on behalf of the AACR
by Hart Research Associates and Public Opinion Strategies.